IOL CHEMICALS & PHARM. | SUDARSHAN PHARMA | IOL CHEMICALS & PHARM./ SUDARSHAN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | - | - | View Chart |
P/BV | x | 1.6 | 1.9 | 82.9% | View Chart |
Dividend Yield | % | 1.0 | 0.4 | 262.7% |
IOL CHEMICALS & PHARM. SUDARSHAN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SUDARSHAN PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ SUDARSHAN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 73 | 732.7% | |
Low | Rs | 272 | 52 | 525.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 191.7 | 197.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 2.9 | 810.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 3.3 | 956.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0.30 | 1,333.3% | |
Avg Dividend yield | % | 1.0 | 0.5 | 206.2% | |
Book value per share (Unadj.) | Rs | 256.8 | 41.9 | 612.2% | |
Shares outstanding (eoy) | m | 58.71 | 24.07 | 243.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.3 | 328.2% | |
Avg P/E ratio | x | 17.1 | 21.4 | 79.8% | |
P/CF ratio (eoy) | x | 12.8 | 18.9 | 67.6% | |
Price / Book Value ratio | x | 1.6 | 1.5 | 105.6% | |
Dividend payout | % | 16.9 | 10.3 | 164.5% | |
Avg Mkt Cap | Rs m | 23,743 | 1,505 | 1,577.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 21 | 8,106.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 4,613 | 480.6% | |
Other income | Rs m | 256 | 11 | 2,292.7% | |
Total revenues | Rs m | 22,427 | 4,624 | 485.0% | |
Gross profit | Rs m | 2,257 | 147 | 1,536.3% | |
Depreciation | Rs m | 462 | 9 | 5,089.3% | |
Interest | Rs m | 165 | 54 | 304.9% | |
Profit before tax | Rs m | 1,887 | 95 | 1,986.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 25 | 2,012.6% | |
Profit after tax | Rs m | 1,391 | 70 | 1,977.3% | |
Gross profit margin | % | 10.2 | 3.2 | 319.7% | |
Effective tax rate | % | 26.2 | 25.9 | 101.3% | |
Net profit margin | % | 6.3 | 1.5 | 411.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,986 | 486.7% | |
Current liabilities | Rs m | 5,025 | 1,185 | 424.1% | |
Net working cap to sales | % | 20.9 | 17.4 | 120.5% | |
Current ratio | x | 1.9 | 1.7 | 114.7% | |
Inventory Days | Days | 43 | 11 | 391.9% | |
Debtors Days | Days | 8 | 645 | 1.3% | |
Net fixed assets | Rs m | 11,017 | 339 | 3,254.2% | |
Share capital | Rs m | 587 | 241 | 244.0% | |
"Free" reserves | Rs m | 14,490 | 769 | 1,884.1% | |
Net worth | Rs m | 15,077 | 1,010 | 1,493.2% | |
Long term debt | Rs m | 0 | 128 | 0.0% | |
Total assets | Rs m | 20,684 | 2,325 | 889.7% | |
Interest coverage | x | 12.5 | 2.8 | 451.6% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 2.0 | 54.0% | |
Return on assets | % | 7.5 | 5.4 | 140.6% | |
Return on equity | % | 9.2 | 7.0 | 132.4% | |
Return on capital | % | 13.6 | 13.1 | 103.9% | |
Exports to sales | % | 26.7 | 0.7 | 3,963.5% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 31 | 19,049.5% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 31 | 19,049.5% | |
Fx outflow | Rs m | 6,052 | 44 | 13,760.3% | |
Net fx | Rs m | -122 | -13 | 947.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -288 | -424.7% | |
From Investments | Rs m | -1,200 | -257 | 467.8% | |
From Financial Activity | Rs m | -41 | 659 | -6.2% | |
Net Cashflow | Rs m | -18 | 115 | -16.0% |
Indian Promoters | % | 48.2 | 57.4 | 84.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.4 | 121.4% | |
FIIs | % | 1.4 | 1.4 | 100.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 42.6 | 121.6% | |
Shareholders | 130,003 | 913 | 14,239.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SUDARSHAN PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.38% | 1.28% | 0.27% |
1-Month | 5.93% | 2.12% | 0.17% |
1-Year | -2.03% | 10.50% | 54.19% |
3-Year CAGR | -12.93% | 4.44% | 15.01% |
5-Year CAGR | 17.47% | 2.64% | 19.86% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SUDARSHAN PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SUDARSHAN PHARMA the stake stands at 57.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SUDARSHAN PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SUDARSHAN PHARMA paid Rs 0.3, and its dividend payout ratio stood at 10.3%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SUDARSHAN PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.